With the untapped market opportunities in oligonucleotides, drug developers are actively seeking help from partners who can provide them with trusted platform technologies, GMP-compliant analytical tools to help them generate robust, reproducible data, as well as CDMOs who can enable seamless tech transfer and scale-up.

The 3rd Oligonucleotides CMC & Analytical Development Summit isn't a tradeshow, it's an opportunity for you to have meaningful, 1-2-1 conversations to foster long-term partnerships, we would love to help you through this dedicated forum and position your brand in front of 100+ industry KOLs to pave the journey in front of us.

Get in touch today to discuss your goals and objectives, and how we can work together with a tailored option to elevate your brand and thought leadership.

Why Partner?

Benefit from Market Intelligence
Expand your networking horizons by meeting 100+ oligonucleotide drug experts across 3-days of networking, data sharing, and case-study analysis to match your solutions to the market

Meet and Network with Industry Pioneers
Promote your brand to powerhouses and newcomers alike, including GSK, Sarepta, Takeda, Alloy Therapeutics, Biogen, and many more 

Raise Brand Awareness and Generate Commercial Collaborations
Unleash the full potential of your brand that'll leave a lasting impression

7+ hours of built-in networking time with CXOs, VPs, and Directors of Discovery, Medicinal and Biological Chemistry


WuXi TIDES LOGO-blue version
ChemGenes_Logo_Blue (1)